BridgeBio Oncology Therapeutics, Inc. 10-Q filing
Filed 2025-08-01 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001213900-25-070659
- Form type
- 10-Q
- CIK
- 0001869105
- Primary document
- https://www.sec.gov/Archives/edgar/data/1869105/000121390025070659/ea0250871-10q_helixacq2.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BridgeBio Oncology Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-3.5M | - | - |
| Net Income | $430,918 | - | - |
| Total Assets | $197.4M | - | - |
| Total Liabilities | $8.1M | - | - |
| Shareholders Equity | $-7.3M | - | - |
| Operating Cash Flow | $-1.0M | - | - |